107 related articles for article (PubMed ID: 18199751)
1. A mechanism for antibody-mediated outside-in activation of LFA-1.
Carreño R; Li D; Sen M; Nira I; Yamakawa T; Ma Q; Legge GB
J Biol Chem; 2008 Apr; 283(16):10642-8. PubMed ID: 18199751
[TBL] [Abstract][Full Text] [Related]
2. Cellular activation of leukocyte function-associated antigen-1 and its affinity are regulated at the I domain allosteric site.
Lupher ML; Harris EA; Beals CR; Sui LM; Liddington RC; Staunton DE
J Immunol; 2001 Aug; 167(3):1431-9. PubMed ID: 11466362
[TBL] [Abstract][Full Text] [Related]
3. 2E8 binds to the high affinity I-domain in a metal ion-dependent manner: a second generation monoclonal antibody selectively targeting activated LFA-1.
Carreño R; Brown WS; Li D; Hernandez JA; Wang Y; Kim TK; Craft JW; Komanduri KV; Radvanyi LG; Hwu P; Molldrem JJ; Legge GB; McIntyre BW; Ma Q
J Biol Chem; 2010 Oct; 285(43):32860-32868. PubMed ID: 20724473
[TBL] [Abstract][Full Text] [Related]
4. Rational design of intercellular adhesion molecule-1 (ICAM-1) variants for antagonizing integrin lymphocyte function-associated antigen-1-dependent adhesion.
Song G; Lazar GA; Kortemme T; Shimaoka M; Desjarlais JR; Baker D; Springer TA
J Biol Chem; 2006 Feb; 281(8):5042-9. PubMed ID: 16354667
[TBL] [Abstract][Full Text] [Related]
5. AL-57, a ligand-mimetic antibody to integrin LFA-1, reveals chemokine-induced affinity up-regulation in lymphocytes.
Shimaoka M; Kim M; Cohen EH; Yang W; Astrof N; Peer D; Salas A; Ferrand A; Springer TA
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):13991-6. PubMed ID: 16963559
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte function-associated antigen 1-mediated adhesion stability is dynamically regulated through affinity and valency during bond formation with intercellular adhesion molecule-1.
Sarantos MR; Raychaudhuri S; Lum AF; Staunton DE; Simon SI
J Biol Chem; 2005 Aug; 280(31):28290-8. PubMed ID: 15955822
[TBL] [Abstract][Full Text] [Related]
7. Identification of the binding site in intercellular adhesion molecule 1 for its receptor, leukocyte function-associated antigen 1.
Fisher KL; Lu J; Riddle L; Kim KJ; Presta LG; Bodary SC
Mol Biol Cell; 1997 Mar; 8(3):501-15. PubMed ID: 9188101
[TBL] [Abstract][Full Text] [Related]
8. The second domain of intercellular adhesion molecule-1 (ICAM-1) maintains the structural integrity of the leucocyte function-associated antigen-1 (LFA-1) ligand-binding site in the first domain.
Stanley P; McDowall A; Bates PA; Brashaw J; Hogg N
Biochem J; 2000 Oct; 351(Pt 1):79-86. PubMed ID: 10998349
[TBL] [Abstract][Full Text] [Related]
9. ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway.
Campanero MR; del Pozo MA; Arroyo AG; Sánchez-Mateos P; Hernández-Caselles T; Craig A; Pulido R; Sánchez-Madrid F
J Cell Biol; 1993 Nov; 123(4):1007-16. PubMed ID: 7901223
[TBL] [Abstract][Full Text] [Related]
10. Activation-induced conformational changes in the I domain region of lymphocyte function-associated antigen 1.
Ma Q; Shimaoka M; Lu C; Jing H; Carman CV; Springer TA
J Biol Chem; 2002 Mar; 277(12):10638-41. PubMed ID: 11792712
[TBL] [Abstract][Full Text] [Related]
11. The lymphocyte function-associated antigen 1 I domain is a transient binding module for intercellular adhesion molecule (ICAM)-1 and ICAM-3 in hydrodynamic flow.
Knorr R; Dustin ML
J Exp Med; 1997 Aug; 186(5):719-30. PubMed ID: 9271587
[TBL] [Abstract][Full Text] [Related]
12. Ligand intercellular adhesion molecule 1 has a necessary role in activation of integrin lymphocyte function-associated molecule 1.
Cabañas C; Hogg N
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5838-42. PubMed ID: 7685913
[TBL] [Abstract][Full Text] [Related]
13. Small molecule inhibitors induce conformational changes in the I domain and the I-like domain of lymphocyte function-associated antigen-1. Molecular insights into integrin inhibition.
Welzenbach K; Hommel U; Weitz-Schmidt G
J Biol Chem; 2002 Mar; 277(12):10590-8. PubMed ID: 11781316
[TBL] [Abstract][Full Text] [Related]
14. The effect of acidic pH on the inhibitory efficacy of peptides against the interaction ICAM-1/LFA-1 studied by surface plasmon resonance (SPR).
Wu SH; Núnez D; Hu SY; Domingo MP; Chen YC; Wei PK; Pardo J; Gálvez EM; Chiou A
Biosens Bioelectron; 2014 Jun; 56():159-66. PubMed ID: 24487103
[TBL] [Abstract][Full Text] [Related]
15. Competition between intercellular adhesion molecule-1 and a small-molecule antagonist for a common binding site on the alphal subunit of lymphocyte function-associated antigen-1.
Keating SM; Clark KR; Stefanich LD; Arellano F; Edwards CP; Bodary SC; Spencer SA; Gadek TR; Marsters JC; Beresini MH
Protein Sci; 2006 Feb; 15(2):290-303. PubMed ID: 16384997
[TBL] [Abstract][Full Text] [Related]
16. Efalizumab binding to the LFA-1 alphaL I domain blocks ICAM-1 binding via steric hindrance.
Li S; Wang H; Peng B; Zhang M; Zhang D; Hou S; Guo Y; Ding J
Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4349-54. PubMed ID: 19258452
[TBL] [Abstract][Full Text] [Related]
17. T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1.
Fortin JF; Cantin R; Tremblay MJ
J Virol; 1998 Mar; 72(3):2105-12. PubMed ID: 9499066
[TBL] [Abstract][Full Text] [Related]
18. Epitope mapping of monoclonal antibody to integrin alphaL beta2 hybrid domain suggests different requirements of affinity states for intercellular adhesion molecules (ICAM)-1 and ICAM-3 binding.
Tang RH; Tng E; Law SK; Tan SM
J Biol Chem; 2005 Aug; 280(32):29208-16. PubMed ID: 15958383
[TBL] [Abstract][Full Text] [Related]
19. Effects of I domain deletion on the function of the beta2 integrin lymphocyte function-associated antigen-1.
Leitinger B; Hogg N
Mol Biol Cell; 2000 Feb; 11(2):677-90. PubMed ID: 10679023
[TBL] [Abstract][Full Text] [Related]
20. Force spectroscopy of the leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction.
Zhang X; Wojcikiewicz E; Moy VT
Biophys J; 2002 Oct; 83(4):2270-9. PubMed ID: 12324444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
